AAAAAA

   
Results: 1-20 |
Results: 20
FOLATE-MAYTANSINOIDS - TARGET-SELECTIVE DRUGS OF LOW-MOLECULAR-WEIGHT
Authors: LADINO CA CHARI RVJ BOURRET LA KEDERSHA NL GOLDMACHER VS
Citation: Ca. Ladino et al., FOLATE-MAYTANSINOIDS - TARGET-SELECTIVE DRUGS OF LOW-MOLECULAR-WEIGHT, International journal of cancer, 73(6), 1997, pp. 859-864
P53 STATUS AFFECTS THE RATE OF THE ONSET BUT NOT THE OVERALL EXTENT OF DOXORUBICIN-INDUCED CELL-DEATH IN RAT-1 FIBROBLASTS CONSTITUTIVELY EXPRESSING C-MYC
Authors: HAN JW DIONNE CA KEDERSHA NL GOLDMACHER VS
Citation: Jw. Han et al., P53 STATUS AFFECTS THE RATE OF THE ONSET BUT NOT THE OVERALL EXTENT OF DOXORUBICIN-INDUCED CELL-DEATH IN RAT-1 FIBROBLASTS CONSTITUTIVELY EXPRESSING C-MYC, Cancer research, 57(1), 1997, pp. 176-182
CONJUGATION OF BLOCKED RICIN TO AN ANTI-CD19 MONOCLONAL-ANTIBODY INCREASES ANTIBODY-INDUCED CELL CALCIUM MOBILIZATION AND CD19 INTERNALIZATION
Authors: GOULET AC GOLDMACHER VS LAMBERT JM BARON C ROY DC KOUASSI E
Citation: Ac. Goulet et al., CONJUGATION OF BLOCKED RICIN TO AN ANTI-CD19 MONOCLONAL-ANTIBODY INCREASES ANTIBODY-INDUCED CELL CALCIUM MOBILIZATION AND CD19 INTERNALIZATION, Blood, 90(6), 1997, pp. 2364-2375
INDUCTION OF APOPTOSIS BY TAMOXIFEN-ACTIVATION OF A P53-ESTROGEN RECEPTOR FUSION PROTEIN EXPRESSED IN E1A AND T24 H-RAS TRANSFORMED P53(- -) MOUSE EMBRYO FIBROBLASTS/
Authors: VATER CA BARTLE LM DIONNE CA LITTLEWOOD TD GOLDMACHER VS
Citation: Ca. Vater et al., INDUCTION OF APOPTOSIS BY TAMOXIFEN-ACTIVATION OF A P53-ESTROGEN RECEPTOR FUSION PROTEIN EXPRESSED IN E1A AND T24 H-RAS TRANSFORMED P53(- -) MOUSE EMBRYO FIBROBLASTS/, Oncogene, 13(4), 1996, pp. 739-748
ERADICATION OF LARGE COLON-TUMOR XENOGRAFTS BY TARGETED DELIVERY OF MAYTANSINOIDS
Authors: LIU CN TADAYONI BM BOURRET LA MATTOCKS KM DERR SM WIDDISON WC KEDERSHA NL ARINIELLO PD GOLDMACHER VS LAMBERT JM BLATTLER WA CHARI RVJ
Citation: Cn. Liu et al., ERADICATION OF LARGE COLON-TUMOR XENOGRAFTS BY TARGETED DELIVERY OF MAYTANSINOIDS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(16), 1996, pp. 8618-8623
EXPRESSION AND SECRETION OF A RECOMBINANT RICIN IMMUNOTOXIN FROM MURINE MYELOMA CELLS
Authors: KREK CE LADINO CA GOLDMACHER VS BLATTLER WA GUILD BC
Citation: Ce. Krek et al., EXPRESSION AND SECRETION OF A RECOMBINANT RICIN IMMUNOTOXIN FROM MURINE MYELOMA CELLS, Protein engineering, 8(5), 1995, pp. 481-489
RICIN-A CHAIN CAN BE CHEMICALLY CROSS-LINKED TO THE MAMMALIAN RIBOSOMAL-PROTEINS L9 AND L10E
Authors: VATER CA BARTLE LM LESZYK JD LAMBERT JM GOLDMACHER VS
Citation: Ca. Vater et al., RICIN-A CHAIN CAN BE CHEMICALLY CROSS-LINKED TO THE MAMMALIAN RIBOSOMAL-PROTEINS L9 AND L10E, The Journal of biological chemistry, 270(21), 1995, pp. 12933-12940
ENHANCEMENT OF THE SELECTIVITY AND ANTITUMOR EFFICACY OF A CC-1065 ANALOG THROUGH IMMUNOCONJUGATE FORMATION
Authors: CHARI RVJ JACKEL KA BOURRET LA DERR SM TADAYONI BM MATTOCKS KM SHAH SA LIU CN BLATTLER WA GOLDMACHER VS
Citation: Rvj. Chari et al., ENHANCEMENT OF THE SELECTIVITY AND ANTITUMOR EFFICACY OF A CC-1065 ANALOG THROUGH IMMUNOCONJUGATE FORMATION, Cancer research, 55(18), 1995, pp. 4079-4084
ANTI-B4-BLOCKED RICIN SYNERGIZES WITH DOXORUBICIN AND ETOPOSIDE ON MULTIDRUG-RESISTANT AND DRUG-SENSITIVE TUMORS
Authors: OCONNOR R LIU CN FERRIS CA GUILD BC TEICHER BA CORVI C LIU YM ARCECI RJ GOLDMACHER VS LAMBERT JM BLATTLER WA
Citation: R. Oconnor et al., ANTI-B4-BLOCKED RICIN SYNERGIZES WITH DOXORUBICIN AND ETOPOSIDE ON MULTIDRUG-RESISTANT AND DRUG-SENSITIVE TUMORS, Blood, 86(11), 1995, pp. 4286-4294
EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA - RESPONSE
Authors: GOLDMACHER VS LAMBERT JM ANDERSON KC
Citation: Vs. Goldmacher et al., EVALUATION OF CD38 AS TARGET FOR IMMUNOTHERAPY IN MULTIPLE-MYELOMA - RESPONSE, Blood, 85(8), 1995, pp. 2283-2284
CHARACTERIZATION OF ANTIBODY-BINDING TO CELL-SURFACE ANTIGENS USING APLASMA MEMBRANE-BOUND PLATE ASSAY
Authors: VATER CA REID K BARTLE LM GOLDMACHER VS
Citation: Ca. Vater et al., CHARACTERIZATION OF ANTIBODY-BINDING TO CELL-SURFACE ANTIGENS USING APLASMA MEMBRANE-BOUND PLATE ASSAY, Analytical biochemistry, 224(1), 1995, pp. 39-50
MUTATIONAL AND STRUCTURAL-ANALYSIS OF THE LECTIN ACTIVITY IN BINDING DOMAIN-2 OF RICIN-B CHAIN
Authors: LEHAR SM PEDERSEN JT KAMATH RS SWIMMER C GOLDMACHER VS LAMBERT JM BLATTLER WA GUILD BC
Citation: Sm. Lehar et al., MUTATIONAL AND STRUCTURAL-ANALYSIS OF THE LECTIN ACTIVITY IN BINDING DOMAIN-2 OF RICIN-B CHAIN, Protein engineering, 7(10), 1994, pp. 1261-1266
ANTI-CD6-BLOCKED RICIN - AN ANTI-PAN T-CELL IMMUNOTOXIN
Authors: COLLINSON AR LAMBERT JM LIU Y ODEA C SHAH SA RASMUSSEN RA GOLDMACHER VS
Citation: Ar. Collinson et al., ANTI-CD6-BLOCKED RICIN - AN ANTI-PAN T-CELL IMMUNOTOXIN, International journal of immunopharmacology, 16(1), 1994, pp. 37-49
HUMANIZATION OF MURINE MONOCLONAL-ANTIBODIES THROUGH VARIABLE DOMAIN RESURFACING
Authors: ROGUSKA MA PEDERSEN JT KEDDY CA HENRY AH SEARLE SJ LAMBERT JM GOLDMACHER VS BLATTLER WA REES AR GUILD BC
Citation: Ma. Roguska et al., HUMANIZATION OF MURINE MONOCLONAL-ANTIBODIES THROUGH VARIABLE DOMAIN RESURFACING, Proceedings of the National Academy of Sciences of the United Statesof America, 91(3), 1994, pp. 969-973
A CYTOTOXICITY ASSAY UTILIZING A FLUORESCENT DYE THAT DETERMINES ACCURATE SURVIVING FRACTIONS OF CELLS
Authors: SELLERS JR COOK S GOLDMACHER VS
Citation: Jr. Sellers et al., A CYTOTOXICITY ASSAY UTILIZING A FLUORESCENT DYE THAT DETERMINES ACCURATE SURVIVING FRACTIONS OF CELLS, Journal of immunological methods, 172(2), 1994, pp. 255-264
ANTI-CD38-BLOCKED RICIN - AN IMMUNOTOXIN FOR THE TREATMENT OF MULTIPLE-MYELOMA
Authors: GOLDMACHER VS BOURRET LA LEVINE BA RASMUSSEN RA POURSHADI M LAMBERT JM ANDERSON KC
Citation: Vs. Goldmacher et al., ANTI-CD38-BLOCKED RICIN - AN IMMUNOTOXIN FOR THE TREATMENT OF MULTIPLE-MYELOMA, Blood, 84(9), 1994, pp. 3017-3025
ANTI-CD38-BLOCKED RICIN - AN IMMUNOTOXIN FOR THE TREATMENT OF MULTIPLE-MYELOMA
Authors: GOLDMACHER VS BOURRET LA LEVINE BA RASMUSSEN RA POURSHADI M LAMBERT JM ANDERSON KC
Citation: Vs. Goldmacher et al., ANTI-CD38-BLOCKED RICIN - AN IMMUNOTOXIN FOR THE TREATMENT OF MULTIPLE-MYELOMA, Blood, 84(9), 1994, pp. 3017-3025
INTERACTIONS OF ANTI-B4-BR WITH CHEMOTHERAPEUTIC-AGENTS ON B-ALL CELLS-INVITRO
Authors: OCONNOR R GOLDMACHER VS TEICHER BA BLATTLER WA
Citation: R. Oconnor et al., INTERACTIONS OF ANTI-B4-BR WITH CHEMOTHERAPEUTIC-AGENTS ON B-ALL CELLS-INVITRO, Journal of cellular biochemistry, 1993, pp. 270-270
EVALUATION OF THE SYSTEMIC TOXICITY AND PHARMACOKINETICS OF THE IMMUNOCONJUGATE ANTI-B4-BLOCKED RICIN IN NONHUMAN-PRIMATES - DELIVERED BY MULTIPLE BOLUS INJECTIONS AND BY CONTINUOUS-INFUSION
Authors: SHAH SA LAMBERT JM GOLDMACHER VS ESBER HJ LEVIN JL CHUNGI V ZUTSHI A BRAMAN GM ARINIELLO PD TAYLOR JA BLATTLER WA
Citation: Sa. Shah et al., EVALUATION OF THE SYSTEMIC TOXICITY AND PHARMACOKINETICS OF THE IMMUNOCONJUGATE ANTI-B4-BLOCKED RICIN IN NONHUMAN-PRIMATES - DELIVERED BY MULTIPLE BOLUS INJECTIONS AND BY CONTINUOUS-INFUSION, International journal of immunopharmacology, 15(6), 1993, pp. 723
THE CD19 SIGNAL-TRANSDUCTION COMPLEX OF B-LYMPHOCYTES - DELETION OF THE CD19 CYTOPLASMIC DOMAIN ALTERS SIGNAL-TRANSDUCTION BUT NOT COMPLEX-FORMATION WITH TAPA-1 AND LEU-13
Authors: BRADBURY LE GOLDMACHER VS TEDDER TF
Citation: Le. Bradbury et al., THE CD19 SIGNAL-TRANSDUCTION COMPLEX OF B-LYMPHOCYTES - DELETION OF THE CD19 CYTOPLASMIC DOMAIN ALTERS SIGNAL-TRANSDUCTION BUT NOT COMPLEX-FORMATION WITH TAPA-1 AND LEU-13, The Journal of immunology, 151(6), 1993, pp. 2915-2927
Risultati: 1-20 |